0000927066-20-000133.txt : 20200610 0000927066-20-000133.hdr.sgml : 20200610 20200610182136 ACCESSION NUMBER: 0000927066-20-000133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROPER WILLIAM L CENTRAL INDEX KEY: 0001087960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 20955716 MAIL ADDRESS: STREET 1: 21250 HAWTHORNE BLVD STREET 2: SUITE 800 CITY: TORRANCE STATE: CA ZIP: 90503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wf-form4_159182767735962.xml FORM 4 X0306 4 2020-06-08 0 0000927066 DAVITA INC. DVA 0001087960 ROPER WILLIAM L C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 1 0 0 0 Common Stock 2020-06-08 4 M 0 4662 81.51 A 20623 D Common Stock 2020-06-08 4 D 0 4305 88.28 D 16318 D Common Stock 2020-06-08 4 S 0 357 86.7885 D 15961 D Stock Appreciation Rights 81.51 2020-06-08 4 M 0 4662 0 D 2016-06-16 2020-06-16 Common Stock 4662.0 0 D Represents the weighted average sale price of $86.7885. The range of prices for the sale of these shares was $86.7701 - $86.8250 rounded to the nearest ten-thousandths. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on June 16, 2015, and 100% vested on June 16, 2016. /s/ Stephanie Berberich, Attorney-in-Fact 2020-06-10